Results 101 to 110 of about 3,093 (146)

Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial. [PDF]

BMC Med
Barchetta I, Filardi T, Dule S, Cimini FA, Sentinelli F, Romagnoli E, Passarella G, Bleve E, Oldani A, Venditti V, Anastasi E, Gandini O, Napoli N, Nicolucci A, Lenzi A, Baroni MG, Morano S, Cavallo MG, SlowDOWN Study Network.   +18 more
europepmc   +1 more source

GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes. [PDF]

PLoS One
Zaveri K, Kulkarni G, Nair R, Shanmugan G, Dharmadhikari SA, Makkar RPS, Jalgaonkar R, Chatterjee BD, Korukonda K, GLIMSI Investigator(s) Study Panel.   +9 more
europepmc   +1 more source

MicroRNAs modulated by DPP-4 inhibitor and bedtime NPH insulin therapy in individuals with type 2 diabetes. [PDF]

Front Endocrinol (Lausanne)
Santos AS, Bando SY, Correa Giannella MLC, da Silva MER.   +3 more
europepmc   +1 more source

Medication Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). [PDF]

Diabetes Care
Gonzalez JS, Wen H, Butera NM, Uschner D, Krause-Steinrauf H, Gramzinski MR, Wexler DJ, Petrovitch H, Hoogendoorn CJ, Crespo-Ramos G, Presley C, Fattaleh B, Lagari V, Walker EA, Cherrington AL, GRADE Research Group*.   +15 more
europepmc   +1 more source

Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes. [PDF]

Int J Mol Sci
Dániel E, Sztanek F, Csiha S, Ratku B, Somodi S, Paragh G, Harangi M, Lőrincz H.   +7 more
europepmc   +1 more source

Therapeutic potential of targeting ceramide for early cardiometabolic lipotoxicity in vivo study. [PDF]

Sci Rep
Shalaby YM, Al-Zohily B, Sudhadev M, Nemmar A, Al-Salam S, Akawi N.   +5 more
europepmc   +1 more source

The possible renoprotective effect of denatonium benzoate in a rat model of type 2 diabetes: role of Krüppel-like factor 6 (KLF6). [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Zakaria HS, El-Fetiany OS, Omar W, Roushdy WN.   +3 more
europepmc   +1 more source

Dual PTP1B/DPP4 Inhibitory Potential of <i>Agathosma betulina</i>, <i>Cymbopogon citratus</i>, and <i>Artemisia afra</i>: Structure-Based Modeling of Phytochemical Leads and Essential Oil Bioassays. [PDF]

Comput Struct Biotechnol J
Adedirin O, Sabiu S.
europepmc   +1 more source

Probing the mechanisms of flavonoids in corn silk for treating type 2 diabetes by in Silico and in vitro experiments. [PDF]

Sci Rep
Liu X, Wu H.
europepmc   +1 more source

Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine. [PDF]

Bioimpacts
Seyfinejad B, Jouyban K, Houshyar J, Jabbaripour Sarmadian A, Jouyban A.   +4 more
europepmc   +1 more source